Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes
Open Access
- 1 June 2005
- journal article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 185 (3) , R1-R8
Abstract
Recently, visfatin was characterized as a novel adipo-cytokine that is upregulated in obesity and exerts insulin-mimetic effects in various tissues. To clarify expression and regulation of this adipocytokine, visfatin mRNA was measured by quantitative real-time reverse transcription-polymerase chain reaction in 3T3-L1 adipocytes during adipogenesis and after treatment with various hormones known to alter insulin sensitivity. Visfatin expression was about 6-fold higher in 3T3-L1 adipocytes in vitro as compared with epididymal fat in vivo and increased during adipogenic conversion more than 3-fold. Interestingly, 100 nM dexamethasone significantly increased visfatin mRNA by almost 1.5-fold. In contrast, 500 ng/ml growth hormone (GH), 10 ng/ml tumor necrosis factor (TNF) α, and 10 μM isoproterenol downregulated visfatin expression by 45%, 36%, and 43% respectively. Insulin did not influence synthesis of this adipocytokine. The effects of dexamethasone, GH, TNFα and isoproterenol were time- and dose-dependent. Furthermore, activation of Gs-protein-coupled pathways by forskolin and cholera toxin was sufficient to significantly downregulate visfatin mRNA. Taken together, our results show a differential regulation of visfatin mRNA by insulin resistance-inducing hormones, supporting the view that this adipo-cytokine might be an interesting novel candidate linking core components of the metabolic syndrome such as obesity and insulin resistance.Keywords
This publication has 22 references indexed in Scilit:
- Regulation of adipocytokines and insulin resistanceDiabetologia, 2003
- Diverse regulation of full-length and truncated growth hormone receptor expression in 3T3-L1 adipocytesMolecular and Cellular Endocrinology, 2003
- The Metabolic Syndrome X And Peripheral Cortisol SynthesisExperimental and Clinical Endocrinology & Diabetes, 2002
- Growth hormone signalling and its regulation: Preventing too much of a good thingGrowth Hormone & IGF Research, 2001
- β3-Adrenergic Stimulation Differentially Inhibits Insulin Signaling and Decreases Insulin-induced Glucose Uptake in Brown AdipocytesJournal of Biological Chemistry, 1999
- The role of TNFα and TNF receptors in obesity and insulin resistanceJournal of Internal Medicine, 1999
- Induction of mRNAs for the growth hormone receptor gene during mouse 3T3-L1 preadipocyte differentiationMetabolism, 1997
- Enhanced sympathetic nervous system activity*The linchpin between insulin resistance, hyperinsulinemia, and heart rateAmerican Journal of Hypertension, 1996
- Hypertension and Associated Metabolic Abnormalities — The Role of Insulin Resistance and the Sympathoadrenal SystemNew England Journal of Medicine, 1996
- 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PONucleic Acids Research, 1991